Folisurge 225IU Injection

Folisurge 225IU injection contains an active component as Follitropin alfa. It is a medication used in assisted reproductive technologies (ART) to treat infertility in both men and women. This synthetic form of follicle-stimulating hormone (FSH) plays a crucial role in stimulating the development of eggs in females and sperm in males. Infertility in men and women refers to the inability to conceive after a year of regular unprotected intercourse.  It stimulates the development of multiple follicles in women, enhances sperm production in men, and provides precise timing for optimal ovulation. With proven efficacy and a generally safe profile, it brings hope to infertile couples, increasing pregnancy rates and shortening treatment duration. Individuals with a known hypersensitivity or allergic reaction to Folisurge 225IU injection or any of its components should avoid its use. Allergic reactions are rare but possible, requiring immediate medical attention. Women with ovarian cysts or tumors should avoid Folisurge 225IU injection, as it may exacerbate these conditions. Patients with uncontrolled hypothyroidism or adrenal dysfunction should not use Folisurge 225IU injection. Uncontrolled hypothyroidism refers to a state where the levels of thyroid hormones remain inadequately regulated, causing persistent symptoms and potential complications. Individuals with abnormalities or blockages in the reproductive tract that prevent successful egg or sperm transport may not benefit from this medication.is not generally recommended for pediatric or elderly populations.